| Literature DB >> 26271759 |
Khaled J Saleh, Alexander J Kurdi, Mouhanad M El-Othmani, Benjamin A Voss, Tony H Tzeng, Jasmine Saleh, Joseph M Lane, William M Mihalko.
Abstract
Rheumatoid arthritis is an autoimmune disease mediated by a widespread chronic systematic inflammatory process that causes joint deterioration, which leads to pain, disability, and poor quality of life. The increased use of disease-modifying antirheumatic drugs has been shown to markedly slow disease progression, which has translated into a decrease in the need for orthopaedic intervention in this population. However, a substantial percentage of patients with the disease fail optimal pharmacologic treatment and still require surgical intervention. A thorough understanding of medical considerations in these patients and improved knowledge of the medical complications caused by the disease process and the pharmacologic therapy used to treat it may lead to improved preoperative planning and medical clearance, which may ultimately improve the overall postoperative outcome. Copyright 2015 by the American Academy of Orthopaedic Surgeons.Entities:
Keywords: disease-modifying antirheumatic drugs; preoperative clearance; rheumatoid arthritis
Mesh:
Substances:
Year: 2015 PMID: 26271759 DOI: 10.5435/JAAOS-D-15-00014
Source DB: PubMed Journal: J Am Acad Orthop Surg ISSN: 1067-151X Impact factor: 3.020